TheraRadar
← Back
Data updated: Mar 29, 2026

BTG INTL

CardiovascularGastroenterology
Specialty

BTG INTL is a specialty pharmaceutical company focused on Cardiovascular, Gastroenterology. Key products include VISTOGARD.

2002
Since
5
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

VISTOGARD
uridine triacetate
6 indications · 2015
XURIDEN
uridine triacetate
1 indications · 2015
AURLUMYN
iloprost
1 indications · 2024

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

AURLUMYN 2024-05-14
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
1 drugs
Gastroenterology 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

BAUSCH specialty
Cardiovascular, Gastroenterology
APOTHECON specialty
Cardiovascular, Gastroenterology
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Gastroenterology
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology